ATG7 and lung carcinoma: Consistently, in prostate cancer, lack of ATG7 delayed tumor cell proliferation (269) and in lung cancer driven by oncogenic Kras, the deletion of ATG7 reduces cell proliferation and tumor weight compared with mice with intact ATG7 (270).